air bubbles in semaglutide syringe Bubble GLP-1 Syringe: Safety Facts and Removal Guide air bubble in semaglutide syringe

On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients (APIs) from manufacturers not included on its newly established Green List.[1] This action follows FDAs September 5 th announcement of the Green List initiative to curb illegal imports of semaglutide, tirzepatide, and other corresponding APIs.[2] Together, the Green List and Import Alert form FDAs most aggressive enforcement measures to date against GLP-1 imports

However, appeals rarely succeed if the denial reason is a plan exclusion rather than medical necessity

This guide explains why GLP-1 medications can cause food aversions and provides practical strategies to help you maintain proper nutrition and eat more comfortably while on treatment

Numerous individuals have reported unbearable stomach pains, an inability to keep down solid foods, and prolonged vomiting and diarrhea